Spectrum Therapeutics announces strategic patient support and education partnership with Medical Pharmacies
Spectrum Therapeutics announces strategic patient support and education partnership with Medical Pharmacies TORONTO & SMITHS FALLS, ON, Aug. 8, 2019 /CNW/ – Spectrum Therapeutics, the medical division of Canopy Growth Corporation (“Canopy Growth”) (TSX: WEED)(NYSE: CGC) today announced that it has entered into a five year service agreement with Medical Pharmacies Group Limited (“Medical Pharmacies”), … Continue reading Spectrum Therapeutics announces strategic patient support and education partnership with Medical Pharmacies
Baxter Launches Prismax In Canada to Maximize Treatment in the Intensive Care Unit
Baxter Launches Prismax In Canada to Maximize Treatment in the Intensive Care Unit Next-generation platform for continuous renal replacement therapy is designed to simplify treatment delivery and accuracy Incorporates latest technology and innovative features inspired by clinician feedback TherMax blood warmer delivers effective blood warming for a variety of organ support therapies MISSISSAUGA, ON, Aug. 12, … Continue reading Baxter Launches Prismax In Canada to Maximize Treatment in the Intensive Care Unit
Biomarker to avoid safety risk for the sleep deprived
Biomarker to avoid safety risk for the sleep deprived UNDER STRICT EMBARGO UNTIL 01.00 GMT 8 AUGUST 2019 Not for publication or broadcast before this time Biomarker to avoid safety risk for the sleep deprived: Eye-movement test indicates sleep loss Lack of sleep can be dangerous; it is thought to play a role in up … Continue reading Biomarker to avoid safety risk for the sleep deprived
Geyser Brands Announces TSX Conditional Approval of Solace Management Group Acquisition
Geyser Brands Announces TSX Conditional Approval of Solace Management Group Acquisition Acquisition will boost Geyser Brand’s product portfolio and financial profile. /THIS NEWS RELEASE, PROVIDED PURSUANT TO APPLICABLE CANADIAN REQUIREMENTS, IS NOT FOR DISTRIBUTION TO U.S. NEWS SERVICES OR FOR DISSEMINATION IN THE UNITED STATES, AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED … Continue reading Geyser Brands Announces TSX Conditional Approval of Solace Management Group Acquisition
LUCA Biologics Launches to Develop Live Biotherapeutics for Women’s Health Starting with Urinary Tract Infection (UTI)
LUCA Biologics Launches to Develop Live Biotherapeutics for Women’s Health Starting with Urinary Tract Infection (UTI) Emerging from 15 years of Dr. Jacques Ravel’s vaginal microbiome research, LUCA’s pipeline targets UTI, bacterial vaginosis (BV), and preterm birth (PTB) TORONTO, ON – August 6, 2019 – LUCA Biologics, a biotechnology company co-founded by Dr. Jacques Ravel, announced today it will develop … Continue reading LUCA Biologics Launches to Develop Live Biotherapeutics for Women’s Health Starting with Urinary Tract Infection (UTI)
